TXMD Stock Analysis: Buy, Sell, or Hold?
TXMD - TherapeuticsMD, Inc.
$2.16
-0.14 (-6.09%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 26, 2026
Smart Money Accumulation
TXMD is down 17.2% this week, but smart money is accumulating calls. Top strike: $3 2026-03-20 with 51 OI. Call ratio: 100% View Scanner →
Strength: 10.0/10
Get Alerted When TXMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: TXMD is down 17.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: TXMD is down 17.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: TXMD is currently trading at $2.16, which is considered fair relative to its 30-day fair value range of $1.80 to $2.44.
Technical Outlook: Technically, TXMD is in a strong uptrend. Immediate support is located at $2.08, while resistance sits at $2.95. Short-term momentum is weak, with the stock down 6.1% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $5.00 (+131.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TXMD is in a strong uptrend. Immediate support is located at $2.08, while resistance sits at $2.95. Short-term momentum is weak, with the stock down 6.1% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $5.00 (+131.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$1.80 -
$2.44
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
75.8%
Protect Your Profits
Holding TXMD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.1%)
- BULLISH: Trading 131.5% below Wall St target ($5.00)
- WARNING: Recommendation downgraded due to -17.2% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$1.80 -
$2.44
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$0.42
(19.3%)
Support & Resistance Levels
Support Level
$2.08
Resistance Level
$2.95
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
2.29
Wall Street Target
$5.00
(+131.5%)
Revenue Growth (YoY)
43.3%
Profit Margin
10.8%
Last updated: February 01, 2026 8:06 AM ET
Data refreshes hourly during market hours. Next update: 9:06 AM
Data refreshes hourly during market hours. Next update: 9:06 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TXMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$179 | 62 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$158 | 56 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$84 | 57 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 55 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$21 | 57 HOLD |
Advanced TXMD Option Strategies
Professional options setups generated by AI based on today's TXMD price and gamma walls.
